The technology is ready to start phase 3 testing in GSK’s asthma product Ventolin (salbutamol) next year, and according to the drugmaker has the potential to reduce greenhouse gas emissions from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback